OverviewSuggest Edit

Adocia is a clinical-stage biotechnology company that specializes in the research and development of innovative formulations of already-approved therapeutic proteins. It operates in the diabetes and other metabolic diseases field. The Company's proprietary technological platform known as BioChaperone is designed to enhance the effectiveness and safety of therapeutic proteins and their ease of use for patients.

TypePublic
Founded2005
HQLyon-3E-Arrondissement, FR
Websiteadocia.com

Latest Updates

Employees (est.) (Sept 2020)132
Share Price (Oct 2020)€7.6 (+3%)
Cybersecurity ratingCMore

Key People/Management at Adocia

Olivier Soula

Olivier Soula

Deputy General Manager, R&D Director
Valérie Danaguezian

Valérie Danaguezian

Chief Financial Officer
Olivier Martinez

Olivier Martinez

Director
Laurent Arthaud

Laurent Arthaud

Director
Ekaterina (Katya

Ekaterina (Katya

Director
Gérard Soula

Gérard Soula

President and CEO
Show more

Adocia Office Locations

Adocia has an office in Lyon-3E-Arrondissement
Lyon-3E-Arrondissement, FR (HQ)
115 Avenue Lacassagne
Show all (1)

Adocia Financials and Metrics

Adocia Revenue

Market capitalization (19-Oct-2020)

52.7m

Closing stock price (19-Oct-2020)

7.6
Adocia's current market capitalization is €52.7 m.
Show all financial metrics

Adocia Cybersecurity Score

Cybersecurity ratingPremium dataset

C

71/100

SecurityScorecard logo

Adocia Online and Social Media Presence

Embed Graph

Adocia News and Updates

Arbitration panel rules in favor of Lilly in complaint filed by Adocia

INDIANAPOLIS, Aug. 22, 2019 /PRNewswire/ -- A Chicago-based arbitration panel has ruled in favor of Eli Lilly and Company (NYSE: LLY) in a claim filed by Adocia S.A. over the companies' prior collaboration on a rapid-acting insulin. The panel of three arbitrators ruled that Lilly acted...

Adocia Blogs

Announcement of Adocia Poster presentation during ADA 2020, a virtual experience next June 12th until 16th, 2020

Adocia announces that an abstract relative to bi-hormonal treatment ADO09 (M1Pram) has been accepted for a poster presentation at the upcoming 80th Scientific Sessions of the American Diabetes Association® (ADA). The ADA annual meeting will take place from June 12th until 16th, 2020 as the inaugural…

April 27, 2020 Adocia conference call is available in transcript and replay

The Conference call scheduled last Monday April 27, 2020 at 6:00 pm (CET) presented Adocia results and provided a business update at the occasion of Adocia Press Release announcing positive topline results of the exploratory Phase 1b study of ADO09 (M1Pram) in people with type 1 diabetes. Speakers: …

Adocia Annual Shareholders’ Meeting on May 28th, 2020 in Lyon

Adocia will hold its annual shareholders’ meeting (“AGM”) on May 28th, 2020, at 10 am at the Company’s headquarter, 115 avenue Lacassagne, 69003, Lyon, France. The notice of this shareholders’ meeting serving as convening notice is published today, in the French Bulletin des Annonces Légales Obligat…

ATTD 2020: Meet the Adocia team and see the E-Poster on M1Pram (ADO09)!

During the 13th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2020) scheduled to take place in Madrid, Spain, 19-22 February 2020, Adocia is pleased to present the E-Poster: “ADO09, A CO-FORMULATION OF THE AMYLIN-ANALOG PRAMLINTIDE AND THE A21G HUMAN INSULIN A…

East-West CEO, the symposium dedicated to investment in health sector

Gerard Soula, ADOCIA CEO, and Steve Daly, ADOCIA US General Manager, attended the #EastWestCEOConference last January 11th and 12th: an introduction to #JPMorganHealthcareConference which is beginning January 13th until January 16th in San Francisco!
Show more

Adocia Frequently Asked Questions

  • When was Adocia founded?

    Adocia was founded in 2005.

  • Who are Adocia key executives?

    Adocia's key executives are Olivier Soula, Valérie Danaguezian and Olivier Martinez.

  • How many employees does Adocia have?

    Adocia has 132 employees.

  • Who are Adocia competitors?

    Competitors of Adocia include Vericel, MODAG and Clover Biopharmaceuticals.

  • Where is Adocia headquarters?

    Adocia headquarters is located at 115 Avenue Lacassagne, Lyon-3E-Arrondissement.

  • Where are Adocia offices?

    Adocia has an office in Lyon-3E-Arrondissement.

  • How many offices does Adocia have?

    Adocia has 1 office.